Drug intelligence / Profile preview

praziquantel

Development stage
Approved
Lead developer
Merck KGaA
Modality
Small Molecules
Administration
Oral
01

Overview

Praziquantel is a small molecule anthelmintic medication used to treat a variety of parasitic worm infections, including schistosomiasis, clonorchiasis, opisthorchiasis, tapeworm infections (such as taeniasis and cysticercosis), echinococcosis, paragonimiasis, fasciolopsiasis, and fasciolosis in humans[3][5]. It is also used in veterinary medicine for similar indications. Praziquantel works primarily by disrupting calcium ion homeostasis in susceptible worms through antagonism of voltage-gated calcium channels. This leads to increased permeability of the parasite's cell membranes to calcium ions, resulting in paralysis and death of the worm[6][3]. The drug was first approved for medical use in 1982 and is included on the World Health Organization's List of Essential Medicines due to its efficacy and low cost[5].

Brand names
Biltricide
Other names
praziquantel
02

Targets

CaV (Voltage-gated calcium channel protein complex)

Beyond the preview

Go deeper on praziquantel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on praziquantel.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call